Please wait while the formulary information is being retrieved.
VELTIN (CLINDAMYCIN PHOSPHATE/TRETINOIN)
- Acne vulgaris
1.2 %-0.025 % topical gel
- Apply to the affected area(s) by topical route once daily at bedtime
1.2 %-0.025 % topical gel
- Apply to the affected area(s) by topical route once daily at bedtime
clindamycin-tretinoin 1.2 %-0.025 % topical gel
- Apply to the affected area(s) by topical route once daily at bedtime
Acne vulgaris
- Apply to the affected area(s) by topical route once daily at bedtime
- None
Contraindicated
- None
Severe
Moderate
- None
- Crohn's disease
- Ulcerative colitis
Contraindicated
- Clostridium difficile infection
- Eczema
- Sunburn
Severe
Moderate
- Atopic dermatitis
VELTIN (CLINDAMYCIN PHOSPHATE/TRETINOIN)
- Acne vulgaris
- Erythema
- Pruritus of skin
- Abnormal desquamation
- Dry skin
- Erythema
- Skin irritation
- Skin photosensitivity
More Frequent
Severe
Less Severe
- Skin rash
- Urticaria
- Headache disorder
- Oily skin
- Stinging of skin
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Anaphylaxis
- Blistering skin
- Bloody diarrhea
- Clostridium difficile infection
- Dyschromia
- Skin crusting
- Skin inflammation
Less Severe
- Acute abdominal pain
- Contact dermatitis
- Diarrhea
- Edema
- Gram-negative folliculitis
- Ocular pain
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Clindamycin (Topical)
Safety and efficacy not established age < 12 years.
- 1 Day – 12 Years
- Safety and efficacy not established age < 12 years.
Tretinoin (Top)
Safety and efficacy not established age < 12 years.
- 1 Day – 12 Years
- Safety and efficacy not established age < 12 years.
Clindamycin (top, Vag)
- Severity Level:
2
- Additional Notes: Insuff human and animal data available
Tretinoin (topical)
- Severity Level:
2
- Additional Notes: Fda cat c; formal consensus lacking regarding safe use of top tretinoin in preg
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Tretinoin (retinoic Or Vit A Acid-top)
Caution should be exercised.
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Caution should be exercised. |
No Known Risk
Clindamycin (top, Vag)
Avoiding nipple area application will reduce infants risk for diarrhea
| General | Excretion Potential | Effect on Infant | Notes |
| No known risks; does not adversely affect lactation | Unknown | Not known; no or inclusive data | Avoiding nipple area application will reduce infants risk for diarrhea |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Acne vulgaris | |
| L70.0 | Acne vulgaris |
| 0-9 | A-Z |
|---|---|
| L70.0 | Acne vulgaris |
Formulary Reference Tool